Distinct gene expression profiles between primary breast cancers and brain metastases from pair-matched samples

Takayuki Iwamoto, Naoki Niikura, Rin Ogiya, +11

Scientific Reports

Breast OncologyBrain MetastasesImmunologyPathologyGene Expression Profiling +16

Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers

Mitsuya Itoh, Takayuki Iwamoto, Junji Matsuoka, +12

Breast Cancer Research and Treatment

Mrna ExpressionBreast OncologyMedicineHormonal ReceptorEstrogen Receptor +9

The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells

Hirokuni Ikeda, Naruto Taira, Fumikata Hara, +8

Breast Cancer Research

A Randomized Controlled Trial Comparing Primary Tumour Resection Plus Systemic Therapy With Systemic Therapy Alone in Metastatic Breast Cancer (PRIM-BC): Japan Clinical Oncology Group Study JCOG1017

Tadahiko Shien, K. Nakamura, Takashi Shibata, +7

Japanese Journal of Clinical Oncology

Surgical OncologyBreast OncologyPathologySurgeryPrimary Systemic Therapy +14

The international collaboration of active surveillance trials for low-risk DCIS (LORIS, LORD, COMET, LORETTA).

Chizuko Kanbayashi, Alastair M. Thompson, Eun-Sil Shelley Hwang, +7

Journal of Clinical Oncology

Surgical OncologyBreast OncologyCancer ManagementSurgeryActive Surveillance Trials +20

Unmet Information Needs and Quality of Life in Young Breast Cancer Survivors in Japan

Mika Miyashita, Shinji Ohno, Akemi Kataoka, +5

Cancer Nursing

Combined inhibition of MEK and PI3K pathways overcomes acquired resistance to EGFR‐TKIs in non‐small cell lung cancer

Hiroki Sato, Hiromasa Yamamoto, Masakiyo Sakaguchi, +13

Cancer Science

21-Gene expression profile assay on core needle biopsies predicts responses to neoadjuvant endocrine therapy in breast cancer patients

Sadako Akashi‐Tanaka, Chikako Shimizu, Masashi Ando, +10

The Breast

Breast OncologyGynecologyPathologyGene Expression ProfilingNaet Responses +15

Tumor inhibitory effect of gefitinib (ZD1839, Iressa) and taxane combination therapy in EGFR‐overexpressing breast cancer cell lines (MCF7/ADR, MDA‐MB‐231)

Daisuke Takabatake, Takeo Fujita, Tadahiko Shien, +7

International Journal of Cancer

Breast OncologyOncologyMedicineCancer Cell BiologyCell Lines +13

Antitumor effect of gefitinib (‘Iressa’) on esophageal squamous cell carcinoma cell lines in vitro and in vivo

Fumikata Hara, Motoi Aoe, Hiroyoshi Doihara, +8

Cancer Letters

Esophageal CancerMedicineCancer Cell BiologyPathology‘ Iressa ’ +7